Gene · 10643
Papers3,038
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 3,038
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The significance of the crosstalk between ubiquitination or deubiquitination and ncRNAs in non-small cell lung cancer. | Front Oncol | 2022 | 36727069 | PubTator, text mining | PubMed |
| A pan-cancer landscape of IGF2BPs and their association with prognosis, stemness and tumor immune microenvironment. | Front Oncol | 2022 | 36686749 | PubTator, text mining | PubMed |
| Genes related to N6-methyladenosine in the diagnosis and prognosis of idiopathic pulmonary fibrosis. | Front Genet | 2022 | 36685949 | PubTator, text mining | PubMed |
| Identification of oncogenes and tumor-suppressor genes with hepatocellular carcinoma: A comprehensive analysis based on TCGA and GEO datasets. | Front Genet | 2022 | 36685860 | PubTator, text mining | PubMed |
| Transcriptomic data analysis coupled with copy number aberrations reveals a blood-based 17-gene signature for diagnosis and prognosis of patients with colorectal cancer. | Front Genet | 2022 | 36685857 | PubTator, text mining | PubMed |
| Construction and validation of a novel ferroptosis-related signature for evaluating prognosis and immune microenvironment in ovarian cancer. | Front Genet | 2022 | 36685851 | PubTator, text mining | PubMed |
| Bioinformatics analysis combined with clinical sample screening reveals that leptin may be a biomarker of preeclampsia. | Front Physiol | 2022 | 36685185 | PubTator, text mining | PubMed |
| Integrated Profiles of Transcriptome and mRNA m6A Modification Reveal the Intestinal Cytotoxicity of Aflatoxin B1 on HCT116 Cells. | Genes (Basel) | 2022 | 36672820 | PubTator, text mining | PubMed |
| Bioinformatics analysis of the correlation between m6A RNA methylation regulators and the immune infiltration and prognosis of bladder cancer. | Ann Transl Med | 2022 | 36660722 | PubTator, text mining | PubMed |
| The landscape of m6A regulators in esophageal cancer: molecular characteristics, immuno-oncology features, and clinical relevance. | Ann Transl Med | 2022 | 36660671 | PubTator, text mining | PubMed |
| Effect of N6-methyladenosine (m6A) regulator-related immunogenes on the prognosis and immune microenvironment of breast cancer. | Transl Cancer Res | 2022 | 36644186 | PubTator, text mining | PubMed |
| Huge Ovarian Tumor: An Unusual Presentation of Gastric-Type Endocervical Adenocarcinoma. | Case Rep Oncol | 2022 | 36636685 | PubTator, text mining | PubMed |
| Surgical Outcomes of Thyroid Nodules Positive for Gene Expression Alterations Using ThyroSeq V3 Genomic Classifier. | Cancers (Basel) | 2022 | 36612045 | PubTator, text mining | PubMed |
| Understanding the Dual Roles of CircHIPK3 in Tumorigenesis and Tumor Progression. | J Cancer | 2022 | 36606192 | PubTator, text mining | PubMed |
| Dynamic regulation and key roles of ribonucleic acid methylation. | Front Cell Neurosci | 2022 | 36601431 | PubTator, text mining | PubMed |
| Interplay of four types of RNA modification writers revealed distinct tumor microenvironment and biological characteristics in pancreatic cancer. | Front Immunol | 2022 | 36601127 | PubTator, text mining | PubMed |
| Immune responses against shared antigens are common in esophago-gastric cancer and can be enhanced using CD40-activated B cells. | J Immunother Cancer | 2022 | 36600602 | PubTator, text mining | PubMed |
| Prognostic and therapeutic implication of m6A methylation in Crohn disease. | Medicine (Baltimore) | 2022 | 36595818 | PubTator, text mining | PubMed |
| m6A regulators featured by tumor immune microenvironment landscapes and correlated with immunotherapy in non-small cell lung cancer (NSCLC). | Front Oncol | 2022 | 36591468 | PubTator, text mining | PubMed |
| Integration analysis identifies MYBL1 as a novel immunotherapy biomarker affecting the immune microenvironment in clear cell renal cell carcinoma: Evidence based on machine learning and experiments. | Front Immunol | 2022 | 36591240 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10643/papers?page=46